Authors' objectives: Based on the 2nd Generation NHI Act 42, health technology assessment (HTA) may be performed on new medical services (diagnostics and procedures) at the time of making reimbursement decisions. In addition to the considerations of human health, medical ethics, cost-effectiveness and health insurance finance are also major issues. Therefore, the aim of this study is to perform a comprehensive evaluation of these emerging treatments including bipolar TURP, bipolar TUVP (vaporization of the prostate), Green Light TM, thulium, holmium, and diode laser prostatectomy. The efficacy and economic literature of 6 surgical procedures was collected and synthesized by systematic review. The report UK, Canada and Australia, as well as international experience through the network of INAHTA were assessed. In addition, domestic status such as clinical application, distribution, prices, and cost analysis was investigated through questionnaires and qualitative interview.
health technology assessment; transurethral resection of the prostate(TURP); bipolar TURP; laser prostatectomy; benign prostatic hyperplasia (BPH); cost-effectiveness analysis; budget impact analysis
10.5
